Kanan Desai
Overview
Explore the profile of Kanan Desai including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
46
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Desai N, Towne W, Connelly C, Baskota S, Crapanzano J, Desai K, et al.
Diagn Cytopathol
. 2025 Mar;
PMID: 40028696
Background: Screening for cervical cancer may include cervical cytology and/or high-risk human papillomavirus testing (HPV). The FDA (Food and Drug Administration)-approved CINtec PLUS dual stain (DS) for p16 and Ki-67...
2.
Ahmed S, Egemen D, Befano B, Rodriguez A, Jeronimo J, Desai K, et al.
PLOS Digit Health
. 2024 Oct;
3(10):e0000364.
PMID: 39356713
A number of challenges hinder artificial intelligence (AI) models from effective clinical translation. Foremost among these challenges is the lack of generalizability, which is defined as the ability of a...
3.
de Sanjose S, Perkins R, Campos N, Inturrisi F, Egemen D, Befano B, et al.
Elife
. 2024 Jan;
12.
PMID: 38224340
Background: The HPV-automated visual evaluation (PAVE) Study is an extensive, multinational initiative designed to advance cervical cancer prevention in resource-constrained regions. Cervical cancer disproportionally affects regions with limited access to...
4.
Ahmed S, Befano B, Lemay A, Egemen D, Rodriguez A, Angara S, et al.
Sci Rep
. 2023 Dec;
13(1):21772.
PMID: 38066031
Cervical cancer is a leading cause of cancer mortality, with approximately 90% of the 250,000 deaths per year occurring in low- and middle-income countries (LMIC). Secondary prevention with cervical screening...
5.
Egemen D, Perkins R, Cheung L, Befano B, Rodriguez A, Desai K, et al.
J Natl Cancer Inst
. 2023 Sep;
116(1):26-33.
PMID: 37758250
Novel screening and diagnostic tests based on artificial intelligence (AI) image recognition algorithms are proliferating. Some initial reports claim outstanding accuracy followed by disappointing lack of confirmation, including our own...
6.
de Sanjose S, Perkins R, Campos N, Inturrisi F, Egemen D, Befano B, et al.
medRxiv
. 2023 Sep;
PMID: 37693492
Objective: To describe the HPV-Automated Visual Evaluation (PAVE) Study, an international, multi-centric study designed to evaluate a novel cervical screen-triage-treat strategy for resource-limited settings as part of a global strategy...
7.
Lopez-Ampuero C, Hansen N, Alvarez Larraondo M, Taipe-Quico R, Cerna-Ayala J, Desai K, et al.
Prev Med
. 2023 Jul;
174:107596.
PMID: 37451555
Cervical cancer screening and treatment of screen positives is an important and effective strategy to reduce cervical cancer morbidity and mortality. In order to have an accurate cervical cancer screening...
8.
Ahmed S, Befano B, Lemay A, Egemen D, Rodriguez A, Angara S, et al.
Res Sq
. 2023 Mar;
PMID: 36909463
Cervical cancer is a leading cause of cancer mortality, with approximately 90% of the 250,000 deaths per year occurring in low- and middle-income countries (LMIC). Secondary prevention with cervical screening...
9.
Demarco M, Egemen D, Hyun N, Chen X, Moscicki A, Cheung L, et al.
J Low Genit Tract Dis
. 2022 Mar;
26(2):127-134.
PMID: 35249974
Objective: The US screening and management guidelines for cervical cancer are based on the absolute risk of precancer estimated from large clinical cohorts and trials. Given the widespread transition toward...
10.
Pal A, Xue Z, Desai K, Aina F Banjo A, Adepiti C, Long L, et al.
Comput Biol Med
. 2021 Oct;
138:104890.
PMID: 34601391
Cervical cancer is a disease of significant concern affecting women's health worldwide. Early detection of and treatment at the precancerous stage can help reduce mortality. High-grade cervical abnormalities and precancer...